DICLOCIEN
Live / Applied — Statement of use — registration review complete (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 29 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98475481
- Mark type
- Stylized text
- Filed
- 29 Mar 2024
- Published for opposition
- 19 Nov 2024
- Attorney of record
- Alondra Andujar
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of minor aches and pains; Pharmaceutical preparations for reducing fevers
Owner
- Medimex USA Inc., Duluth, GA, US
- Medimex USA Inc., Duluth, GA, US
Prosecution history
- 01 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Mar 2026 — ASSIGNED TO LIE
- 12 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Jan 2026 — NON-FINAL ACTION E-MAILED
- 14 Jan 2026 — SU - NON-FINAL ACTION - WRITTEN
- 21 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Jun 2025 — USE AMENDMENT FILED
- 21 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 19 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 19 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED